Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Epizyme, Inc.
  6. News
  7. Summary
    EPZM   US29428V1044

EPIZYME, INC.

(EPZM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about EPIZYME, INC.
10/08EPIZYME : Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
AQ
10/07EPIZYME : Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
09/15EPIZYME : Announces Data from TAZVERIK (Tazemetostat) Clinical Programs to be Presented Du..
AQ
09/14EPIZYME : Announces Data from TAZVERIK« (Tazemetostat) Clinical Programs to be Presented D..
BU
08/23EPIZYME : Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
AQ
08/20EPIZYME : Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
08/16EPIZYME : FIFTH AMENDMENT TO LEASE (Form 8-K)
PU
08/10EPIZYME : Morgan Stanley Lowers Epizyme to Underweight From Equal-Weight, Price Target to ..
MT
08/10EPIZYME : HC Wainwright Adjusts Epizyme's Price Target to $15 From $36, Maintains Buy Rati..
MT
08/10EPIZYME : Wedbush Cuts Epizyme's Price Target to $12 From $26, Citing 'Lower-Than-Expected..
MT
08/09EPIZYME : and HUTCHMED Announce Strategic Collaboration to Develop and Commercialize TAZVE..
AQ
08/09EPIZYME : Q2 Loss Widens, Revenue Rises; Company Names Grant Bogle as New CEO - Shares Dec..
MT
08/09EPIZYME : Q2 Earnings Snapshot
AQ
08/09EPIZYME : Announces CEO Succession
BU
08/09Epizyme, Inc. Announces Management Changes
CI
More most relevant news
All news about EPIZYME, INC.
10/08EPIZYME : Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
AQ
10/07EPIZYME : Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
09/15EPIZYME : Announces Data from TAZVERIK (Tazemetostat) Clinical Programs to be Presented Du..
AQ
09/14EPIZYME : Announces Data from TAZVERIK« (Tazemetostat) Clinical Programs to be Presented D..
BU
08/23EPIZYME : Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
AQ
08/20EPIZYME : Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
08/16EPIZYME : FIFTH AMENDMENT TO LEASE (Form 8-K)
PU
08/16EPIZYME, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhib..
AQ
08/10EPIZYME : Morgan Stanley Lowers Epizyme to Underweight From Equal-Weight, Price Target to ..
MT
08/10EPIZYME : HC Wainwright Adjusts Epizyme's Price Target to $15 From $36, Maintains Buy Rati..
MT
More news
News in other languages on EPIZYME, INC.
2020Roche erhält US-Zulassung für Cobas Diagnostiktest bei Follikulärem Lymphom
2020ROCHE : test Cobas validé par la FDA contre le lymphome folliculaire
More news
Analyst Recommendations on EPIZYME, INC.
08/10EPIZYME : Morgan Stanley Lowers Epizyme to Underweight From Equal-Weight, Price Target to ..
MT
08/10EPIZYME : HC Wainwright Adjusts Epizyme's Price Target to $15 From $36, Maintains Buy Rati..
MT
08/10EPIZYME : Wedbush Cuts Epizyme's Price Target to $12 From $26, Citing 'Lower-Than-Expected..
MT
05/07EPIZYME : Morgan Stanley Adjusts Epizyme's Price Target to $10 From $11, Keeps Equal-Weigh..
MT
05/07EPIZYME : SVB Leerink Upgrades Epizyme to Outperform From Market Perform, Adjusts Price Ta..
MT
More recommendations
Press releases
10/08EPIZYME : Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
AQ
10/07EPIZYME : Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
09/15EPIZYME : Announces Data from TAZVERIK (Tazemetostat) Clinical Programs to be Presented Du..
AQ
09/14EPIZYME : Announces Data from TAZVERIK« (Tazemetostat) Clinical Programs to be Presented D..
BU
08/23EPIZYME : Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
AQ
More press releases
Upcoming event on EPIZYME, INC.
11/03/21